Summary: "The vector of anti-PD-1 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human PD-1. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-PD-1 antibody linked to a CD28 transmembrane domain/ endodomain and FcεRIγ signaling domains. And the vector product was designed for the treatment of B-cell malignancies. https://www.creative-biolabs.com/car-t/pcdcar1-pd-1-h-28fc%CE%B5ri%CE%B3-t-470.htm"